Auxano Advisors’s AbbVie ABBV Stock Holding History

Auxano Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	4,344 +134	+3%	+$28.8K	0.21%	74
2026 Q1	$916K	Buy	4,210 +3	+0.1%	+$665	0.18%	85
2025 Q4	$961K	Buy	4,207 +161	+4%	+$36.7K	0.19%	73
2025 Q3	$937K	Sell	4,046 -10	-0.2%	-$2.04K	0.2%	62
2025 Q2	$753K	Buy	4,056 +35	+0.9%	+$6.5K	0.18%	74
2025 Q1	$842K	Buy	4,021 +519	+15%	+$101K	0.22%	65
2024 Q4	$622K	Sell	3,502 -429	-11%	-$78.9K	0.16%	85
2024 Q3	$776K	Buy	3,931 +502	+15%	+$93.7K	0.2%	80
2024 Q2	$588K	Sell	3,429 -168	-5%	-$27.8K	0.16%	89
2024 Q1	$655K	Buy	3,597 +1,313	+57%	+$226K	0.19%	83
2023 Q4	$354K	Sell	2,284 -101	-4%	-$14.7K	0.12%	101
2023 Q3	$356K	Hold	2,385	–	–	0.15%	73
2023 Q2	$380K	Hold	2,385	–	–	0.15%	72
2023 Q1	$380K	Hold	2,385	–	–	0.15%	72
2022 Q4	$385K	Hold	2,385	–	–	0.17%	68
2022 Q3	$320K	Buy	+2,385	New	+$342K	0.15%	72
2022 Q2	–	Sell	-1,267	Closed	-$205K	–	80
2022 Q1	$205K	Buy	+1,267	New	+$184K	0.09%	78

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Auxano Advisors's ABBV Position: Q2 2026 in Review

Auxano Advisors increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $28.8K and bringing the position to 4,344 shares worth $1.09M. The position accounts for 0.21% of the portfolio, ranked #74.

Auxano Advisors first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Auxano Advisors held 4,344 shares of AbbVie worth $1.09M as of Q2 2026.
Auxano Advisors bought 134 AbbVie shares in Q2 2026, an estimated $28.8K.
AbbVie made up 0.21% of Auxano Advisors's portfolio in Q2 2026, its #74 holding.
Auxano Advisors first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Auxano Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.